Keratins and keratin-associated proteins (KAPs) constitute the major structural protein components of the hair. Regulation of their expression is critical for proper hair follicle (HF) structure and function [1] . Therefore, it is important to fully elucidate the controls that regulate keratin expression. Although it is accepted that the expression of selected keratin genes underlies endocrine controls [1, 2] , our understanding of the complex regulation of keratin expression remains rather fragmentary. To better elucidate this regulation, human skin and HF organ culture offer an instructive, physiologically relevant research tool [1, 3] .
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In particular, very little is known on the neuroendocrine controls of keratin transcription. The importance of the latter is highlighted by the recent discovery that the "pituitary" neuropeptide hormone, prolactin, which is also expressed by human HFs, potently regulates the expression of selected human keratins on the gene and protein level [3] . Moreover, microarray analyses had provided first clues that thyroid stimulating hormone (TSH) and its proximal regulator in the hypothalamic-pituitary-thyroid axis, thyrotropin-releasing hormone (TRH), might operate as previously unsuspected modulators of human hair keratin and KAP gene transcription in situ [4] [5] [6] . Also, we had recently found that TSH upregulates keratin K5 gene expression and protein synthesis as well as K14 transcription in human epidermis [4] . Therefore, we have asked whether TSH operates as a novel neuroendocrine regulator of human keratins in situ, using microdissected, organ-cultured human scalp HFs as a physiologically and clinically relevant assay systems [3] [4] [5] . This was complemented by studying the effect of TSH on keratin expression in cultured human outer root sheath (ORS) keratinocytes (KCs).
Anagen VI HFs were isolated from normal frontotemporal scalp skin obtained after written informed consent from three healthy females undergoing routine face-lift surgery, as previously described [4, 5] , adhering to Helsinki guidelines and under a licence from the ethics committee of the University of Lübeck. HF mRNA extracts from one female patient were subjected to quantitative real time PCR (qPCR) for selected hair keratin genes after 24 hrs treatment with TSH (100 mU ml -1 ) or vehicle. For immunohistochemical analysis, isolated
HFs from additional two female patients were organ cultured for 6 days as described previously [3, 4] , and expression of keratins K6, K14, K17, K31, K32, K85 and MSX-2 was studied with our previously published basic immunohistology protocols [3, 4] ( Table 1 ). For epithelial keratin qPCR experiments, human ORS KCs were obtained from an additional female patient, as previously described [3] . These were treated for 24h with TSH (100 mU ml -1 ) or vehicle.
Our previous microarray results had suggested that TSH administration significantly downregulates expression of K31 [4] , thus suggesting a role for TSH in the regulation of hair keratins. To further explore this microarray lead, we performed qPCR on carefully selected hair keratins that are expressed in the hair shaft-generating HF epithelium, representing three major compartments of the HF epithelium: the hair matrix/precortex and cuticle (K35), the hair cortex (K31) and the hair cuticle (K32) [2] . Particular emphasis was placed on studying KRT85 and KRT35 transcription, since both keratins are the earliest ones to be expressed in the precortical hair matrix and early cuticle [2] .
These qPCR analyses demonstrated that TSH downregulated transcription of KRT31 and KRT32 genes (Fig. 1A) . In these qPCR analyses, KRT35 transcription was largely unaffected by TSH. Instead, transcription of its type II counterpart keratin gene, KRT85 [2] , was downregulated (Fig. 1A) .
Immunohistochemical studies on TSH treated HFs confirmed the downregulation of the hair keratins also at the protein level ( Fig. 2A-C ): K31 immunoreactivity, localized to the hair cortex ( Fig. 2A) , K85 immunoreactivity, which is expressed in the hair cortex and in the precortical hair matrix (Fig. 2B) and K32 immunoreactivity, which serves as a marker for the hair cuticle (Fig. 2C) , were significantly downregulated following TSH administration. Since MSX2 serves as a major transcription factor that regulates hair keratin expression [7] , analysis of MSX2 expression was also performed. Indeed, TSH downregulated MSX2 transcription in human anagen HFs in situ (Fig. 1A) . MSX2 immunoreactivity was found to correspond to the expression pattern in the mouse, the hair matrix and cortex (Fig. 2D ) [8] . In line with the qPCR results, TSH downregulated MSX2 immunoreactivity (Fig. 2D ).
Several epithelial keratins are widely expressed in the HF ORS, where they are thought to play an important role in maintaining structural integrity and homeostasis [1] . We have previously confirmed that TSH has a regulatory effect on K5 [4] , which is prominently expressed in the ORS [1] . We have therefore further explored this finding, by studying the effects of TSH on selected epithelial keratins which are constitutively expressed in the ORS [2] . HF treatment with TSH significantly downregulated K6, K14 and K17 immunoreactivity ( Fig. 2E-G) . In order to confirm these findings in isolated HF KCs in situ, TSH treated ORS KCs were analyzed by qPCR. This showed a significant downregulation of KRT6 and KRT17
transcription, but no effect on KRT14 transcription (Fig. 1B) .
Exploiting the human HF as a discovery tool for keratin research, the current pilot study identifies TSH as a novel neuroendocrine regulator of keratin expression in human skin. The data provided here also suggest that the hair shaft abnormalities seen in patients with hyperor hypothyroidism [9] may result not only from perturbations in the thyroid hormone blood 5 levels, but also from associated neuroendocrine changes in TSH levels in the blood, or even in the skin [6, 10] .
The regulation of hair keratin gene expression is tightly controlled by a complex mechanism involving several upstream mediators. These include members of the Wnt/β-catenin pathway and of the TGF-β family which control MSX2, FOXN1 and HOXC13 activity [1, 2, 7, 11, 12] .
Since MSX2 is a major regulator of hair shaft differentiation, our observation that TSH reduces MSX2 expression on the gene and protein level encourages one to pursue the hypothesis that TSH may act at least in part via inhibiting MSX2 expression.
While KRT35 transcription was not inhibited by TSH, TSH downregulated KRT85 expression. Such a unilateral keratin regulation has been documented before for the cuticle keratin K82 [13] . It is conceivable that the TSH-induced upregulation of KAPs transcription previously observed by microarray analysis [4] may compensate for the downregulation of one type of keratin, as an attempt to maintain structural stability of the hair shaft.
In summary, our pilot study reveals that the expression of selected HF keratins underlies novel neuroendocrine controls, possibly as part of the unfolding hypothalamus-pituitarythyroid axis equivalent present in human skin [4] [5] [6] 10] . As shown for prolactin [3] and TSH, human HF organ culture offers an excellent research tool to further dissect "novel"
neuroendocrine in situ-controls that drive keratin expression in the human system under clinically relevant conditions on the gene and protein level. 
